CD19/BCMA CAR-NK cells

CAR-NK cell therapy targeting CD19 and BCMA · The Children's Hospital of Zhejiang University School of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19/BCMA CAR-NK cells, covering 2026-02-03 to 2026-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related Autoimmune Diseases [EARLY_Phase 1]

See pricing